Journal article

Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid

Blaine R Roberts, James D Doecke, Alan Rembach, L Fernanda Yevenes, Christopher J Fowler, Catriona A McLean, Monica Lind, Irene Volitakis, Colin L Masters, Ashley I Bush, Dominic J Hare

ACTA NEUROPATHOLOGICA COMMUNICATIONS | BMC | Published : 2016

Abstract

Loss of intracellular compartmentalization of potassium is a biochemical feature of Alzheimer's disease indicating a loss of membrane integrity and mitochondrial dysfunction. We examined potassium and rubidium (a biological proxy for potassium) in brain tissue, blood fractions and cerebrospinal fluid from Alzheimer's disease and healthy control subjects to investigate the diagnostic potential of these two metal ions. We found that both potassium and rubidium levels were significantly decreased across all intracellular compartments in the Alzheimer's disease brain. Serum from over 1000 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL), showed min..

View full abstract